000 | 01441 a2200385 4500 | ||
---|---|---|---|
005 | 20250515061358.0 | ||
264 | 0 | _c20070411 | |
008 | 200704s 0 0 eng d | ||
022 | _a1744-7623 | ||
024 | 7 |
_a10.1517/14728214.12.1.113 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGilron, Ian | |
245 | 0 | 0 |
_aEmerging drugs in neuropathic pain. _h[electronic resource] |
260 |
_bExpert opinion on emerging drugs _cMar 2007 |
||
300 |
_a113-26 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAdenosine _xagonists |
650 | 0 | 4 |
_aAnalgesics _xtherapeutic use |
650 | 0 | 4 |
_aAnalgesics, Opioid _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnticonvulsants _xtherapeutic use |
650 | 0 | 4 |
_aCannabinoids _xtherapeutic use |
650 | 0 | 4 |
_aCatecholamines _xagonists |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeuralgia _xdrug therapy |
650 | 0 | 4 |
_aNicotinic Agonists _xtherapeutic use |
650 | 0 | 4 |
_aNicotinic Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aTRPV Cation Channels _xagonists |
700 | 1 | _aCoderre, Terence J | |
773 | 0 |
_tExpert opinion on emerging drugs _gvol. 12 _gno. 1 _gp. 113-26 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/14728214.12.1.113 _zAvailable from publisher's website |
999 |
_c16911236 _d16911236 |